AM251
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 510338

CAS#: 183232-66-8

Description: AM251 is a cannabinoid receptor antagonist. AM251 improves recognition memory in rats and produces nocifensive behavior via activation of ERK signaling pathway. Moreover, AM251 alters mitochondrial physiology via proteolytic degradation of ERRα and attenuates mechanical allodynia and thermal hyperalgesia after burn injury.


Chemical Structure

img
AM251
CAS# 183232-66-8

Theoretical Analysis

MedKoo Cat#: 510338
Name: AM251
CAS#: 183232-66-8
Chemical Formula: C22H21Cl2IN4O
Exact Mass: 554.01371
Molecular Weight: 555.24
Elemental Analysis: C, 47.59; H, 3.81; Cl, 12.77; I, 22.86; N, 10.09; O, 2.88

Price and Availability

Size Price Availability Quantity
10.0mg USD 150.0 2 Weeks
25.0mg USD 250.0 2 Weeks
50.0mg USD 450.0 2 Weeks
100.0mg USD 650.0 2 Weeks
200.0mg USD 950.0 2 Weeks
500.0mg USD 1650.0 2 Weeks
1.0g USD 2850.0 2 Weeks
2.0g USD 4350.0 2 Weeks
5.0g USD 9750.0 2 Weeks
Click to view more sizes and prices
Bulk inquiry

Synonym: AM251; AM 251; AM-251.

IUPAC/Chemical Name: 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide

InChi Key: BUZAJRPLUGXRAB-UHFFFAOYSA-N

InChi Code: InChI=1S/C22H21Cl2IN4O/c1-14-20(22(30)27-28-11-3-2-4-12-28)26-29(19-10-7-16(23)13-18(19)24)21(14)15-5-8-17(25)9-6-15/h5-10,13H,2-4,11-12H2,1H3,(H,27,30)

SMILES Code: O=C(C1=NN(C2=CC=C(Cl)C=C2Cl)C(C3=CC=C(I)C=C3)=C1C)NN4CCCCC4

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO, not in water

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Product Data:

Biological target: AM251 is a selective cannabinoid 1 (CB1) receptor antagonist with an IC50 of 8 nM, also acts as a potent GPR55 agonist with an EC50 of 39 nM.
In vitro activity: However, TGF-β effect was inhibited in the presence of CB1 agonist ACEA 1 μM in association with CB1 selective antagonist AM251 10 μM (24.76 ± 6.43 vs 2.03 ± 0.87, P = 0.0451, statistically significant). Moreover, CB1 antagonist alone also prevented TGF-β effect on α-SMA expressions (24.76 ± 6.43 vs 1.74 ± 1.15, P = 0.0451, statistically significant). In this context, this study evaluated the effect of this drug at concentrations of 1 μM, 5 μM and 10 μM in the fibroblast primary culture activated with TGF-β. AM251 inhibited the TGF-β effect on α-SMA expression in a concentration-dependent manner (Fig. 4). This effect was significant at concentrations ≥1 μM (all P < 0.05vsTGF-β), reaching a maximum at the concentration of 5 μM. Reference: Eur J Pharmacol. 2021 Feb 5;892:173738. https://pubmed.ncbi.nlm.nih.gov/33220269/
In vivo activity: As anticipated, a 5 mg·kg−1, i.p. dose of CB‐13 induced hypothermia in ABH mice (Figure 1), which has been shown previously to be CB1 receptor‐mediated and completely absent in CB1 receptor‐deficient mice. This induced significant visible sedation and also induced hypothermia, which was measured to provide a quantitative readout. The hypothermic effect was rapidly antagonized with AM251 (5 mg·kg−1, i.v.; Figure 1), and the significant marked sedation, associated with the relative lack of motility, was lost within 20 min. The hypothermia was lost by 40 min after treatment with AM251 (Figure 1). Therefore, a CB1 receptor inverse agonist can reverse CB1 receptor‐mediated cannabimimetic effects. Reference: Br J Pharmacol. 2017 Nov; 174(21): 3790–3794. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5647190/

Solubility Data

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
DMSO 36.38 65.52
DMF 10.0 18.01
Ethanol 14.0 25.21

Preparing Stock Solutions

The following data is based on the product molecular weight 555.24 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol: 1. Correia-Sá IB, Carvalho CM, Serrão PV, Machado VA, Carvalho SO, Marques M, Vieira-Coelho MA. AM251, a cannabinoid receptor 1 antagonist, prevents human fibroblasts differentiation and collagen deposition induced by TGF-β - An in vitro study. Eur J Pharmacol. 2021 Feb 5;892:173738. doi: 10.1016/j.ejphar.2020.173738. Epub 2020 Nov 19. PMID: 33220269. 2. Yoshinaga T, Uwabe K, Naito S, Higashino K, Nakano T, Numata Y, Kihara A. AM251 Suppresses Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells. PLoS One. 2016 Dec 9;11(12):e0167848. doi: 10.1371/journal.pone.0167848. PMID: 27936102; PMCID: PMC5148003. 3. Parihar VK, Syage A, Flores L, Lilagan A, Allen BD, Angulo MC, Song J, Smith SM, Arechavala RJ, Giedzinski E, Limoli CL. The Cannabinoid Receptor 1 Reverse Agonist AM251 Ameliorates Radiation-Induced Cognitive Decrements. Front Cell Neurosci. 2021 Jun 28;15:668286. doi: 10.3389/fncel.2021.668286. PMID: 34262437; PMCID: PMC8273551. 4. Pryce G, Baker D. Antidote to cannabinoid intoxication: the CB1 receptor inverse agonist, AM251, reverses hypothermic effects of the CB1 receptor agonist, CB-13, in mice. Br J Pharmacol. 2017 Nov;174(21):3790-3794. doi: 10.1111/bph.13973. Epub 2017 Sep 20. PMID: 28800377; PMCID: PMC5647190.
In vitro protocol: 1. Correia-Sá IB, Carvalho CM, Serrão PV, Machado VA, Carvalho SO, Marques M, Vieira-Coelho MA. AM251, a cannabinoid receptor 1 antagonist, prevents human fibroblasts differentiation and collagen deposition induced by TGF-β - An in vitro study. Eur J Pharmacol. 2021 Feb 5;892:173738. doi: 10.1016/j.ejphar.2020.173738. Epub 2020 Nov 19. PMID: 33220269. 2. Yoshinaga T, Uwabe K, Naito S, Higashino K, Nakano T, Numata Y, Kihara A. AM251 Suppresses Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells. PLoS One. 2016 Dec 9;11(12):e0167848. doi: 10.1371/journal.pone.0167848. PMID: 27936102; PMCID: PMC5148003.
In vivo protocol: 1. Parihar VK, Syage A, Flores L, Lilagan A, Allen BD, Angulo MC, Song J, Smith SM, Arechavala RJ, Giedzinski E, Limoli CL. The Cannabinoid Receptor 1 Reverse Agonist AM251 Ameliorates Radiation-Induced Cognitive Decrements. Front Cell Neurosci. 2021 Jun 28;15:668286. doi: 10.3389/fncel.2021.668286. PMID: 34262437; PMCID: PMC8273551. 2. Pryce G, Baker D. Antidote to cannabinoid intoxication: the CB1 receptor inverse agonist, AM251, reverses hypothermic effects of the CB1 receptor agonist, CB-13, in mice. Br J Pharmacol. 2017 Nov;174(21):3790-3794. doi: 10.1111/bph.13973. Epub 2017 Sep 20. PMID: 28800377; PMCID: PMC5647190.

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Liu J, Pope C. The cannabinoid receptor antagonist AM251 increases paraoxon and chlorpyrifos oxon toxicity in rats. Neurotoxicology. 2015 Jan;46:12-8. doi: 10.1016/j.neuro.2014.11.001. Epub 2014 Nov 20. PubMed PMID: 25447325.

2: Ren Y, Wang J, Xu PB, Xu YJ, Miao CH. Systemic or intra-amygdala infusion of an endocannabinoid CB1 receptor antagonist AM251 blocked propofol-induced anterograde amnesia. Neurosci Lett. 2015 Jan 1;584:287-91. doi: 10.1016/j.neulet.2014.11.001. Epub 2014 Nov 6. PubMed PMID: 25445359.

3: Ueda M, Iwasaki H, Wang S, Murata E, Poon KY, Mao J, Martyn JA. Cannabinoid receptor type 1 antagonist, AM251, attenuates mechanical allodynia and thermal hyperalgesia after burn injury. Anesthesiology. 2014 Dec;121(6):1311-9. doi: 10.1097/ALN.0000000000000422. PubMed PMID: 25188001; PubMed Central PMCID: PMC4237656.

4: Ratano P, Everitt BJ, Milton AL. The CB1 receptor antagonist AM251 impairs reconsolidation of pavlovian fear memory in the rat basolateral amygdala. Neuropsychopharmacology. 2014 Oct;39(11):2529-37. doi: 10.1038/npp.2014.103. Epub 2014 May 7. PubMed PMID: 24801769; PubMed Central PMCID: PMC4149486.

5: Krzysik-Walker SM, González-Mariscal I, Scheibye-Knudsen M, Indig FE, Bernier M. The biarylpyrazole compound AM251 alters mitochondrial physiology via proteolytic degradation of ERRα. Mol Pharmacol. 2013 Jan;83(1):157-66. doi: 10.1124/mol.112.082651. Epub 2012 Oct 12. PubMed PMID: 23066093; PubMed Central PMCID: PMC3533472.

6: Aydin C, Oztan O, Isgor C. Nicotine-induced anxiety-like behavior in a rat model of the novelty-seeking phenotype is associated with long-lasting neuropeptidergic and neuroplastic adaptations in the amygdala: effects of the cannabinoid receptor 1 antagonist AM251. Neuropharmacology. 2012 Dec;63(8):1335-45. doi: 10.1016/j.neuropharm.2012.08.016. Epub 2012 Aug 31. PubMed PMID: 22959963; PubMed Central PMCID: PMC3697052.

7: Naderi N, Majidi M, Mousavi Z, Khoramian Tusi S, Mansouri Z, Khodagholi F. The interaction between intrathecal administration of low doses of palmitoylethanolamide and AM251 in formalin-induced pain related behavior and spinal cord IL1-β expression in rats. Neurochem Res. 2012 Apr;37(4):778-85. doi: 10.1007/s11064-011-0672-2. Epub 2011 Dec 27. PubMed PMID: 22201038.

8: Bialuk I, Winnicka MM. AM251, cannabinoids receptors ligand, improves recognition memory in rats. Pharmacol Rep. 2011;63(3):670-9. PubMed PMID: 21857077.

9: Raffa RB, Ward SJ. CB₁-independent mechanisms of Δ⁹-THCV, AM251 and SR141716 (rimonabant). J Clin Pharm Ther. 2012 Jun;37(3):260-5. doi: 10.1111/j.1365-2710.2011.01284.x. Epub 2011 Jul 11. Review. PubMed PMID: 21740450.

10: Dono LM, Currie PJ. The cannabinoid receptor CB₁ inverse agonist AM251 potentiates the anxiogenic activity of urocortin I in the basolateral amygdala. Neuropharmacology. 2012 Jan;62(1):192-9. doi: 10.1016/j.neuropharm.2011.06.019. Epub 2011 Jul 1. PubMed PMID: 21736884.

AM251

10.0mg / USD 150.0


Additional Information